Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Gocovri®(amantadine) – New indication
February 1, 2021 - Adamas Pharma announced the FDA approval of Gocovri (amantadine), as adjunctive treatment to levodopa/carbidopa in patients with Parkinson’s disease experiencing “off” episodes.
